| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Inozyme Pharma Inc (NASDAQ: INZY)
INZY Technical Analysis
1.5
| As on 9th Jun 2023 INZY STOCK Price closed @ 6.10 and we RECOMMEND Buy for LONG-TERM with Stoploss of 4.32 & Sell for SHORT-TERM with Stoploss of 6.62 we also expect STOCK to react on Following IMPORTANT LEVELS. |
INZYSTOCK Price
| Open | 5.96 | Change | Price | % |
| High | 6.25 | 1 Day | 0.14 | 2.35 |
| Low | 5.86 | 1 Week | 0.18 | 3.04 |
| Close | 6.10 | 1 Month | 0.35 | 6.09 |
| Volume | 444284 | 1 Year | -1.44 | -19.10 |
| 52 Week High 7.55 | 52 Week Low 1.05 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| INZY Daily Charts |
INZY Intraday Charts |
Whats New @ Bazaartrend |
INZY Free Analysis |
|
|
INZY Important Levels Intraday
| RESISTANCE | 6.85 |
| RESISTANCE | 6.61 |
| RESISTANCE | 6.46 |
| RESISTANCE | 6.31 |
| SUPPORT | 5.89 |
| SUPPORT | 5.74 |
| SUPPORT | 5.59 |
| SUPPORT | 5.35 |
INZY Forecast May 2024
| 4th UP Forecast | 9.92 |
| 3rd UP Forecast | 8.69 |
| 2nd UP Forecast | 7.94 |
| 1st UP Forecast | 7.18 |
| 1st DOWN Forecast | 5.02 |
| 2nd DOWN Forecast | 4.26 |
| 3rd DOWN Forecast | 3.51 |
| 4th DOWN Forecast | 2.28 |
INZY Weekly Forecast
| 4th UP Forecast | 9.16 |
| 3rd UP Forecast | 8.18 |
| 2nd UP Forecast | 7.57 |
| 1st UP Forecast | 6.97 |
| 1st DOWN Forecast | 5.23 |
| 2nd DOWN Forecast | 4.63 |
| 3rd DOWN Forecast | 4.02 |
| 4th DOWN Forecast | 3.04 |
INZY Forecast2024
| 4th UP Forecast | 19.61 |
| 3rd UP Forecast | 15.28 |
| 2nd UP Forecast | 12.6 |
| 1st UP Forecast | 9.92 |
| 1st DOWN Forecast | 2.28 |
| 2nd DOWN Forecast | -0.4 |
| 3rd DOWN Forecast | -3.08 |
| 4th DOWN Forecast | -7.41 |
Inozyme Pharma Inc ( NASDAQ USA Symbol : INZY )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
INZY Business Profile
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. Address: 321 Summer Street, Boston, MA, United States, 02210
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service